Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.
- C. Antzelevitch, P. Brugada, A. Wilde
- MedicineCirculation
- 8 February 2005
The present report elaborates further on the diagnostic criteria and examines risk stratification schemes and device and pharmacological approaches to therapy on the basis of the available clinical and basic science data.
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS)…
- M. Ackerman, S. Priori, D. Zipes
- MedicineEuropace
- 1 August 2011
This international consensus statement provides the state of genetic testing for the channelopathies and cardiomyopathies. It summarizes the opinion of the international writing group members based…
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
- Qiuyun Chen, G. Kirsch, Qing Wang
- Biology, MedicineNature
- 19 March 1998
It is shown that sodium channels with the missense mutation recover from inactivation more rapidly than normal and that the frameshift mutation causes the sodium channel to be non-functional.
Brugada syndrome: report of the second consensus conference.
- C. Antzelevitch, P. Brugada, A. Wilde
- MedicineHeart Rhythm
- 1 April 2005
Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG
- R. Brugada, K. Hong, C. Antzelevitch
- Medicine, BiologyCirculation
- 15 December 2003
The genetic basis for a new clinical entity characterized by sudden death and short-QT intervals in the ECG is described and a novel genetic and biophysical mechanism responsible for sudden death in infants, children, and young adults caused by mutations in KCNH2 is demonstrated.
Proposed diagnostic criteria for the Brugada syndrome: consensus report.
- A. Wilde, C. Antzelevitch, J. Towbin
- MedicineCirculation
- 5 November 2002
The electrocardiographic signature of the Brugada syndrome is dynamic and often concealed, but can be unmasked by potent sodium channel blockers such as flecainide, ajmaline, and procainamide, although the specificity of this effect for uncovering patients at risk for sudden death has been an issue of concern.
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
- Jamie D. Kapplinger, D. Tester, M. Ackerman
- Medicine, BiologyHeart Rhythm
- 2010
Long-Term Follow-Up of Individuals With the Electrocardiographic Pattern of Right Bundle-Branch Block and ST-Segment Elevation in Precordial Leads V1 to V3
- J. Brugada, R. Brugada, C. Antzelevitch, J. Towbin, K. Nademanee, P. Brugada
- MedicineCirculation
- 2002
An ECG showing right bundle-branch block and ST-segment elevation in the right precordial leads is a marker of malignant ventricular arrhythmias and sudden death.
Proposed diagnostic criteria for the Brugada syndrome.
- A. Wilde, C. Antzelevitch, J. Towbin
- MedicineEuropean Heart Journal
- 1 November 2002
In regions of Southeast Asia where it is endemic, the clinical presentation of Brugada syndrome is distinguished by a male predominance and the appearance of arrhythmic events at an average age of 40 years.
Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.
- R. Dumaine, J. Towbin, C. Antzelevitch
- Biology, MedicineCirculation Research
- 29 October 1999
The findings explain the features of the ECG of Brugada patients, illustrate for the first time a cardiac sodium channel mutation of which the arrhythmogenicity is revealed only at temperatures approaching the physiological range, and suggest that some patients may be more at risk during febrile states.
...
...